VYNE Therapeutics Merger with Yarrow Expected Early Week of July 27

VYNE Therapeutics Inc. announced updates regarding its previously disclosed merger with Yarrow Bioscience, Inc., a special cash dividend, and a reverse stock split. The special cash dividend was distributed on July 23, 2026, with an ex-dividend date of July 24, 2026. A 1-for-50 reverse stock split is expected on July 24, 2026, with post-split trading commencing on July 27, 2026. The closing of the merger with Yarrow is anticipated early in the week of July 27, 2026, subject to Nasdaq approval, after which the combined company will trade as "Yarrow Bioscience, Inc." under the ticker YARW.